DD275052A1 - Verfahren zur herstellung von 2,3,4,5,6,7-hexahydro-2,7-methano-1,5-benzoxozorin bzw.-1,4-benzoxazonin-verbindungen - Google Patents

Verfahren zur herstellung von 2,3,4,5,6,7-hexahydro-2,7-methano-1,5-benzoxozorin bzw.-1,4-benzoxazonin-verbindungen Download PDF

Info

Publication number
DD275052A1
DD275052A1 DD87306749A DD30674987A DD275052A1 DD 275052 A1 DD275052 A1 DD 275052A1 DD 87306749 A DD87306749 A DD 87306749A DD 30674987 A DD30674987 A DD 30674987A DD 275052 A1 DD275052 A1 DD 275052A1
Authority
DD
German Democratic Republic
Prior art keywords
general formula
compounds
hydrogen atom
alkyl
methano
Prior art date
Application number
DD87306749A
Other languages
German (de)
English (en)
Inventor
Friedrich Eiden
Peter Gmeiner
Juergen Schuenemann
Original Assignee
Madaus & Co Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Madaus & Co Dr filed Critical Madaus & Co Dr
Publication of DD275052A1 publication Critical patent/DD275052A1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/08—Bridged systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/08—Bridged systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DD87306749A 1986-09-08 1987-09-07 Verfahren zur herstellung von 2,3,4,5,6,7-hexahydro-2,7-methano-1,5-benzoxozorin bzw.-1,4-benzoxazonin-verbindungen DD275052A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19863630539 DE3630539A1 (de) 1986-09-08 1986-09-08 Derivate von 2,3,4,5,6,7-hexahydro-2,7-methano-1,5-benzoxazonin (bzw. -1,4-benzoxazonin), verfahren zu ihrer herstellung und arzneimittel, die diese verbindung enthalten

Publications (1)

Publication Number Publication Date
DD275052A1 true DD275052A1 (de) 1990-01-10

Family

ID=6309142

Family Applications (1)

Application Number Title Priority Date Filing Date
DD87306749A DD275052A1 (de) 1986-09-08 1987-09-07 Verfahren zur herstellung von 2,3,4,5,6,7-hexahydro-2,7-methano-1,5-benzoxozorin bzw.-1,4-benzoxazonin-verbindungen

Country Status (29)

Country Link
US (1) US4859664A (xx)
JP (1) JPS6377882A (xx)
KR (1) KR910002566B1 (xx)
CN (1) CN1020103C (xx)
AR (1) AR243190A1 (xx)
AT (1) ATA185987A (xx)
AU (1) AU590443B2 (xx)
BE (1) BE1002121A4 (xx)
CH (1) CH675723A5 (xx)
CS (1) CS621687A2 (xx)
DD (1) DD275052A1 (xx)
DE (1) DE3630539A1 (xx)
DK (1) DK464487A (xx)
ES (1) ES2013322A6 (xx)
FI (1) FI88800C (xx)
FR (1) FR2603587B1 (xx)
GB (1) GB2194786B (xx)
GR (1) GR871209B (xx)
HU (1) HU203106B (xx)
IL (1) IL83156A (xx)
IT (1) IT1228437B (xx)
NL (1) NL8701938A (xx)
NO (1) NO168530C (xx)
PL (1) PL154258B1 (xx)
PT (1) PT85656B (xx)
SE (1) SE8703343L (xx)
SU (1) SU1565346A3 (xx)
YU (1) YU46068B (xx)
ZA (1) ZA876657B (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0344981B1 (en) * 1988-06-01 1994-08-03 Smithkline Beecham Corporation Alpha-adrenergic receptor antagonists
CA1320486C (en) * 1988-06-01 1993-07-20 John J. Lafferty .alpha. -adrenergic receptor antagonists
US4959360A (en) * 1988-06-01 1990-09-25 Smithkline Beecham Corporation α-adrenergic receptor antagonists
US4963547A (en) * 1988-06-01 1990-10-16 Smithkline Beecham Corporation Alpha-andrenergic receptor antagonists and use thereas
EP0344979B1 (en) * 1988-06-01 1994-11-09 Smithkline Beecham Corporation Alfa-adrenergic receptor antagonists
DE4102103A1 (de) * 1991-01-25 1992-08-20 Bayer Ag Substituierte benzoxazepine und benzthiazepine, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
US5248645A (en) * 1992-09-01 1993-09-28 Phillips Petroleum Company Ethylene oligomerization

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3124583A (en) * 1964-03-10 Substituted derivatives of
US3118900A (en) * 1962-01-15 1964-01-21 Abbott Lab Substituted derivatives of 3-aza-6, 7-benzo-8-oxa-5-phenylbicyclo[3.3.1]-nonane
US3401166A (en) * 1966-08-01 1968-09-10 Squibb & Sons Inc Therapeutically active benzothiazines
US3446820A (en) * 1967-04-03 1969-05-27 Rexall Drug Chemical Substituted benzoxazocines and intermediates
US3869475A (en) * 1973-04-05 1975-03-04 Yissum Res Dev Co 2,6-methano-benzoxacin compounds
JPS50106985A (xx) * 1973-05-08 1975-08-22
US4100277A (en) * 1976-11-08 1978-07-11 American Home Products Corporation 4,1-Benzoxazonine derivatives and process therefor
AU6119980A (en) * 1979-08-09 1981-02-12 Glaxo Group Limited Benzoxocin derivatives

Also Published As

Publication number Publication date
SE8703343D0 (sv) 1987-08-28
GB2194786B (en) 1991-01-02
FR2603587A1 (fr) 1988-03-11
US4859664A (en) 1989-08-22
CN1020103C (zh) 1993-03-17
ATA185987A (de) 1994-05-15
PL154258B1 (en) 1991-07-31
ES2013322A6 (es) 1990-05-01
ZA876657B (en) 1988-03-08
SE8703343L (sv) 1988-03-09
GB8716668D0 (en) 1987-08-19
YU46068B (sh) 1992-12-21
NO168530B (no) 1991-11-25
FR2603587B1 (fr) 1991-02-01
DK464487D0 (da) 1987-09-07
IL83156A (en) 1992-12-01
PT85656B (pt) 1990-05-31
CN87106267A (zh) 1988-04-13
IT8721436A0 (it) 1987-07-24
NO873727L (no) 1988-03-09
NL8701938A (nl) 1988-04-05
CH675723A5 (xx) 1990-10-31
SU1565346A3 (ru) 1990-05-15
DK464487A (da) 1988-03-09
IT1228437B (it) 1991-06-17
GR871209B (en) 1987-11-30
PT85656A (en) 1987-10-01
FI873852A0 (fi) 1987-09-07
AU590443B2 (en) 1989-11-02
PL267628A1 (en) 1989-06-12
AU7816287A (en) 1988-03-10
BE1002121A4 (fr) 1990-07-17
DE3630539A1 (de) 1988-03-10
JPH0319236B2 (xx) 1991-03-14
NO168530C (no) 1992-03-04
CS621687A2 (en) 1990-09-12
HUT50180A (en) 1989-12-28
KR910002566B1 (ko) 1991-04-26
AR243190A1 (es) 1993-07-30
NO873727D0 (no) 1987-09-07
FI873852A (fi) 1988-03-09
JPS6377882A (ja) 1988-04-08
HU203106B (en) 1991-05-28
IL83156A0 (en) 1987-12-31
FI88800C (fi) 1993-07-12
KR880003945A (ko) 1988-05-31
GB2194786A (en) 1988-03-16
FI88800B (fi) 1993-03-31

Similar Documents

Publication Publication Date Title
DE2265255C2 (de) 2-Aminoäthylhexahydrophenanthren-Derivate und deren Säureadditionssalze
CH648553A5 (de) Neue 3,4-dihydro-5h-2,3-benzodiazepin-derivate und verfahren zur herstellung derselben.
DE2506770A1 (de) Piperidinderivate
DE2125634A1 (de) Verfahren zur Herstellung von neuen Cycloheptenderivaten
DE2002840A1 (de) 2,3,5-trisubstit,-2'-Hydroxy-6,7-benzomorphane und Verfahren zu deren Herstellung
DE2027077A1 (de) 6,7-Benzomorphane, Verfahren zu ihrer Herstellung und ihre Verwendung
EP0000220B1 (de) Dihydrouracile, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel
DE3002367A1 (de) 2-substituierte trans-5-aryl-2,3,4,4a,5, 9b-hexahydro-1h-pyrido eckige klammer auf 4,3-b eckige klammer zu indole
DE69828999T2 (de) 1-(4-(1-(4-fluorophenyl)-1h-indol-3-yl)1-butyl)-spiro-(isobenzofuran-1(3h),4'-pperidin)-hydrohalogenide
DE2811031C2 (de) Piperazino-3-indole, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
DD275052A1 (de) Verfahren zur herstellung von 2,3,4,5,6,7-hexahydro-2,7-methano-1,5-benzoxozorin bzw.-1,4-benzoxazonin-verbindungen
DE1795832C3 (de) O-Aminoarylketimine und Verfahren zu ihrer Herstellung
DE2633889C2 (de) Neue Aminobenzocyclohepten-Derivate und deren Salze, Verfahren zu ihrer Herstellung und pharmazeutische Zusammensetzungen
DE68905363T2 (de) Heterotetracyclische laktamderivate, verfahren zu ihrer herstellung und pharmazeutische zubereitungen, die sie enthalten.
DD141156A5 (de) Verfahren zur herstellung von 4a-aryl-octahydro-1h-2-pyrindinen
DE2748466A1 (de) 4a-aryloctahydro-1h-2-pyrindine
DE2542791C2 (de) N,N'-Disubstituierte Naphthylacetamidine
DE19830105C1 (de) Acridinderivate
DE2526966A1 (de) Tricyclische alkylaminverbindungen, verfahren zu ihrer herstellung und sie enthaltende mittel
DE2348577A1 (de) L-amino-4-phenyltetralin-derivate und diese enthaltende pharmazeutische zubereitung
EP0273168A1 (de) Triazaspirodecanylmethylindolon-Derivate
DE3019019A1 (de) Pyrazolo eckige klammer auf 1,5-c eckige klammer zu chinazolinderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
CH513807A (de) Verfahren zur Herstellung von tricyclischen Verbindungen
DE2748468A1 (de) Trans-5a-aryl-decahydrobenzazepine und verfahren zu ihrer herstellung
EP0013424A1 (de) Spiro(dibenz(b,f)thiepin-piperidine), Zwischenprodukte zu ihrer Herstellung und sie enthaltende Arzneimittel

Legal Events

Date Code Title Description
RPV Change in the person, the name or the address of the representative (searches according to art. 11 and 12 extension act)
ENJ Ceased due to non-payment of renewal fee